MiRXES gains 24.5% after HK IPO launch
Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 p.m. local time. The company plans to use most of the IPO proceeds to fund R&D and commercialize its early cancer detection solutions.